Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
KVLQT1 / KCNQ1 is a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene.
Gene Name: | potassium voltage-gated channel, KQT-like subfamily, member 1 |
Family/Subfamily: | Ion Channel , Potassium channel - KCNQ |
Synonyms: | KCNQ1, ATFB1, ATFB3, KVLQT1, LQT1, KCNA9, KQT-like 1, Kv1.9, ROMANO-WARD SYNDROME, LQT, SQT2, JLNS1, KCNA8, Kv7.1, RWS, WRS |
Target Sequences: | NM_000218 NP_000209.2 P51787 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.